Q4 2024 Management View Paul Hudson highlighted significant progress in 2024 towards becoming a focused science-driven ...
Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback